Altis Biosystems, Inc. is a biotechnology startup company, which has developed a stem cell technology, recreating both the small or large human intestinal epithelium for drug testing and microbiome research. Our primary stem cells proliferate into all of the normal differentiated cells that you would expect to see in the intestinal epithelium, creating a contiguous monolayer of cells. It is meant to replace Caco-2 cells and animal testing, for compound screening. Altis’s product is high throughput, scalable, reproducible, and uses normal human tissue derived from transplant-grade donor organs. Our goal is to make drug discovery faster, cheaper, safer and reduce the need for animal testing. Altis sells its platform as a service to pharmaceutical companies. Some of the services it provides are toxicology, permeability, transport, ELISA, flow cytometry, immunostaining, high-content imaging and more. The platform can also be shipped to customers for in-house testing, if they prefer.
Altis Biosystems has not received any reviews.
Altis Biosystems has not received any endorsements.